Skip to content
Is “Femtech” the Next Big Thing in Healthcare?


Clue allows women to do just that with just a few clicks on their smartphone. Today the company has a lot of competition in the area of ​​period tracking and fertility. And many other tools specific to women have entered the market. Elvie, a London-based company, has marketed a portable breast pump and pelvic exercise trainer and app, both using smart technology. Another part of femtech known as “menotech” aims to improve the lifestyle of women during their menopause, giving them access to telemedicine and to information and data that women can use.

Credit…Index

Finally, there are medical technology companies focused on cancer that affects women, such as cervical cancer and breast cancer.

Cervical cancer is the fourth most common cause of cancer in women worldwide, according to the World Health Organization. In 2018, approximately 570,000 women were affected and up to 311,000 died. WHO announced in November a program to eradicate the disease completely by 2030.

Tel Aviv-based startup MobileODT uses smartphones and artificial intelligence to screen for cervical cancer. A smart colposcope – a portable imaging device that is one and a half times the size of a smartphone – is used to take a photo of a woman’s cervix from a distance of about one meter (3 feet ). The image is then transmitted to the cloud via a smartphone, where artificial intelligence is used to identify normal or abnormal cervical findings.

A diagnosis is issued in about 60 seconds – compared to the weeks it takes to receive the results of a standard smear test (which in developing countries takes several months). In addition to this screening, doctors still use smear tests.

The technology was recently used to screen 9,000 women over a three-month period in the Dominican Republic as part of a government-led campaign, the company said last month. An additional 50,000 women are expected to be screened over the next six months.

Leon Boston, the South African-born CEO of MobileODT, said the private company sells to around 20 different countries, including the United States, India, South Korea and Brazil, and is embarking on a fundraising to build on its initial capital of $ 24 million.



Source link